Horizon Therapeutics Common
|
12.6 |
$810M |
|
7.0M |
115.69 |
United Therapeutics Corp Common
(UTHR)
|
10.0 |
$644M |
|
2.9M |
225.87 |
Argenx Se Sponsored ADR
(ARGX)
|
7.7 |
$492M |
|
1.0M |
491.63 |
Sarepta Therapeutics Common
(SRPT)
|
7.6 |
$488M |
|
4.0M |
121.22 |
Apellis Pharmaceuticals Common
(APLS)
|
6.6 |
$423M |
|
11M |
38.04 |
Seagen Common
|
5.8 |
$373M |
|
1.8M |
212.15 |
Ascendis Pharma Sponsored ADR
(ASND)
|
5.4 |
$344M |
|
3.7M |
93.64 |
Biomarin Pharmaceutical Common
(BMRN)
|
5.3 |
$341M |
|
3.9M |
88.48 |
Amicus Therapeutics Common
(FOLD)
|
5.2 |
$333M |
|
27M |
12.16 |
Krystal Biotech Common
(KRYS)
|
4.6 |
$298M |
|
2.6M |
116.00 |
Mirati Therapeutics Common
|
4.5 |
$290M |
|
6.7M |
43.56 |
Madrigal Pharmaceuticals Common
(MDGL)
|
3.5 |
$227M |
|
1.6M |
146.04 |
Alnylam Pharmaceuticals Common
(ALNY)
|
2.8 |
$179M |
|
1.0M |
177.10 |
Xenon Pharmaceuticals Common
(XENE)
|
2.6 |
$167M |
|
4.9M |
34.16 |
Cymabay Therapeutics Common
|
2.4 |
$154M |
|
10M |
14.91 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
1.8 |
$114M |
|
2.0M |
57.00 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.3 |
$82M |
|
12M |
7.08 |
Roivant Sciences Common
(ROIV)
|
0.8 |
$54M |
|
4.7M |
11.68 |
Kymera Therapeutics Common
(KYMR)
|
0.8 |
$54M |
|
3.9M |
13.90 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.8 |
$54M |
|
1.5M |
35.65 |
Structure Therapeutics Sponsored ADR
(GPCR)
|
0.8 |
$50M |
|
1.0M |
50.42 |
Nuvalent Common
(NUVL)
|
0.6 |
$37M |
|
813k |
45.97 |
Mannkind Corp Common
(MNKD)
|
0.6 |
$37M |
|
9.0M |
4.13 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.6 |
$37M |
|
2.6M |
14.52 |
Iovance Biotherapeutics Common
(IOVA)
|
0.5 |
$31M |
|
6.7M |
4.55 |
Akero Therapeutics Ord Common
(AKRO)
|
0.4 |
$28M |
|
556k |
50.58 |
Kura Oncology Common
(KURA)
|
0.4 |
$27M |
|
3.0M |
9.12 |
Rocket Pharmaceuticals Common
(RCKT)
|
0.4 |
$26M |
|
1.3M |
20.49 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.4 |
$25M |
|
3.2M |
8.05 |
Tango Therapeutics Common
(TNGX)
|
0.4 |
$25M |
|
2.2M |
11.26 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.3 |
$22M |
|
4.5M |
4.79 |
Cerevel Therapeutics Hldng Common
(CERE)
|
0.3 |
$21M |
|
956k |
21.83 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.3 |
$18M |
|
3.0M |
6.14 |
Avidity Biosciences Common
(RNA)
|
0.2 |
$16M |
|
2.5M |
6.38 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.2 |
$15M |
|
565k |
26.87 |
Aadi Biosciences Common
(AADI)
|
0.2 |
$14M |
|
2.8M |
4.84 |
Taysha Gene Therapies Common
(TSHA)
|
0.2 |
$12M |
|
3.9M |
3.16 |
Verrica Pharmaceuticals Common
(VRCA)
|
0.2 |
$12M |
|
3.0M |
3.88 |
Merus N V Common
(MRUS)
|
0.2 |
$11M |
|
444k |
23.58 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$9.0M |
|
1.2M |
7.51 |
Ikena Oncology Common
(IKNA)
|
0.1 |
$7.1M |
|
1.6M |
4.33 |
Seres Therapeutics Common
(MCRB)
|
0.1 |
$6.0M |
|
2.5M |
2.38 |
Io Biotech Common
(IOBT)
|
0.0 |
$2.8M |
|
2.1M |
1.38 |
Talaris Therapeutics Common
|
0.0 |
$1.4M |
|
500k |
2.81 |
Invesco QQQ Trust Etf Put Option
(QQQ)
|
0.0 |
$1.2M |
|
500k |
2.44 |
Aeglea Biotherapeutics Common
(SYRE)
|
0.0 |
$140k |
|
12k |
12.25 |